Logistics & Transportation

Articles

Although it still has to undergo the preclinical and clinical trial process, the DNA vaccine—which could be created in as little as six weeks—does not require the cold chain storage that mRNA jabs often demand.

Touchlight, University of Nottingham Collaborate on Development of Zika Vaccine

The 86,000 square-foot Køge facility will be fully functional by 2027. 

Novo Financially Commits $220 Million Toward New Plant in Denmark

The facility will focus on furthering RNA and DNA-based therapies. 

Boston Seaport Now Home to Lilly’s New Research and Development Center

Even as pharma technology evolves, and payers argue over reimbursement 
practices throughout healthcare, drug wholesaling is a thriving business.


US Drug Wholesaling 2024: Staying the Course

The CDMO will also be adding new equipment for the manufacture of oligonucleotides and peptides.

Asymchem Officially Introduces Small Molecule Development, API Pilot Plant 

The parties’ combined portfolio help tackle the rising demand for advanced cell and gene therapies.  

MilliporeSigma Finalizes Mirus Bio Deal

The pre-approval pertains to a solid oral dose product that the CDMO will manufacture for a global pharmaceutical company. 

Almac Charnwood Commercial Manufacturing Plant Successfully Passes FDA Inspection

The San Antonio facility will be taking this biomanufacturing initiative by the end of Q3 2024.

Scorpius to Unveil First Mammalian cGMP Campaign at Texas Plant

The deal exponentially grows the CDMO’s biopharma capabilities.

Agilent Purchases Biovectra for $925 Million

In a transaction valued at $250 million, the deal makes Grünenthal the new owner of Movantik, which treats OIC in adult patients with chronic non-cancer pain. 

Manufacturing & Packaging